The ambition of the European Respiratory Journal continues: chapter 5 Marc Humbert, Anh Tuan Dinh-Xuan, Elin L. Reeves, Matthew G. Broadhead, Neil J. Bullen Eur Respir J 2017; 49(1): 1602393; DOI: 10.1183/13993003.02393-2016 | |
Predicting the future from the past Alvar Agustí Eur Respir J 2017; 49(1): 1601854; DOI: 10.1183/13993003.01854-2016 | |
The era of research collaborations: new models for working together Ratko Djukanovi?, Guy Bruselle, Samantha Walker, Stephen T. Holgate, Sabina Škrgat, Piotr Kuna, Liam G. Heaney, G. WalterCanonica, Jørgen Vestbo Eur Respir J 2017; 49(1): 1601848; DOI: 10.1183/13993003.01848-2016 | |
Through a glass darkly: inhaled corticosteroids, airway inflammation and COPD Peter M.A. Calverley Eur Respir J 2017; 49(1): 1602201; DOI: 10.1183/13993003.02201-2016 | |
Group 5 drugs for multidrug-resistant tuberculosis: is the glass half full or half empty? Giovanni Sotgiu, Giovanni Battista Migliori Eur Respir J 2017; 49(1): 1602273; DOI: 10.1183/13993003.02273-2016 | |
?1-Antitrypsin deficiency: count me in please! Joan B. Soriano, Ravi Mahadeva Eur Respir J 2017; 49(1): 1601941; DOI: 10.1183/13993003.01941-2016 | |
The time is right for an international primary ciliary dyskinesia disease registry Kenan Haver Eur Respir J 2017; 49(1): 1602143; DOI: 10.1183/13993003.02143-2016 | |
Symptoms, signs, suspicion and setting: a PESI score for cancer-associated pulmonary embolism? Florian Posch, Cihan Ay Eur Respir J 2017; 49(1): 1602225; DOI: 10.1183/13993003.02225-2016 | |
Professor Neil B. Pride (1931–2016) Peter J. Barnes Eur Respir J 2017; 49(1): 1602343; DOI: 10.1183/13993003.02343-2016 | |
The Art of Breathing: Tidal Tom Kotsimbos, Gary P. Anderson Eur Respir J 2017; 49(1): 1704901; DOI: 10.1183/13993003.04901-2017 | |
2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung Brian L. Graham, Vito Brusasco, Felip Burgos, Brendan G. Cooper, Robert Jensen, Adrian Kendrick, Neil R. MacIntyre, Bruce R.Thompson, Jack Wanger Eur Respir J 2017; 49(1): 1600016; DOI: 10.1183/13993003.00016-2016 | |
Executive Summary: 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung Brian L. Graham, Vito Brusasco, Felip Burgos, Brendan G. Cooper, Robert Jensen, Adrian Kendrick, Neil R. MacIntyre, Bruce R.Thompson, Jack Wanger Eur Respir J 2017; 49(1): 16E0016; DOI: 10.1183/13993003.E0016-2016 | |
European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia Jane S. Lucas, Angelo Barbato, Samuel A. Collins, Myrofora Goutaki, Laura Behan, Daan Caudri, Sharon Dell, Ernst Eber, Estelle Escudier, Robert A. Hirst, Claire Hogg, Mark Jorissen, Philipp Latzin, Marie Legendre, Margaret W. Leigh, Fabio Midulla, Kim G. Nielsen, Heymut Omran, Jean-François Papon, Petr Pohunek, Beatrice Redfern, David Rigau, Bernhard Rindlisbacher, Francesca Santamaria, Amelia Shoemark, Deborah Snijders, Thomy Tonia Eur Respir J 2017; 49(1): 1601090; DOI: 10.1183/13993003.01090-2016 | |
Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Lisette I.Z. Kunz, Nick H.T. ten Hacken, Thérèse S. Lapperre, Wim Timens, Huib A.M. Kerstjens, Annemarie van Schadewijk, Judith M. Vonk, Jacob K. Sont, Jiska B. Snoeck-Stroband, Dirkje S. Postma, Peter J. Sterk, Pieter S.Hiemstra, the GLUCOLD Study Group Eur Respir J 2017; 49(1): 1600839; DOI: 10.1183/13993003.00839-2016 | |
The prevalence of diagnosed ?1-antitrypsin deficiency and its comorbidities: results from a large population-based database Timm Greulich, Christoph Nell, David Hohmann, Marco Grebe, Sabina Janciauskiene, Andreas Rembert Koczulla, Claus Franz Vogelmeier Eur Respir J 2017; 49(1): 1600154; DOI: 10.1183/13993003.00154-2016 | |
Group 5 drugs for multidrug-resistant tuberculosis: individual patient data meta-analysis Greg J. Fox, Andrea Benedetti, Helen Cox, Won-Jung Koh, Piret Viiklepp, Shama Ahuja, Geoffrey Pasvol, Dick Menzies,on behalf of the Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB Eur Respir J 2017; 49(1): 1600993; DOI: 10.1183/13993003.00993-2016 | |
The international primary ciliary dyskinesia cohort (iPCD Cohort): methods and first results Myrofora Goutaki, Elisabeth Maurer, Florian S. Halbeisen, Israel Amirav, Angelo Barbato, Laura Behan, Mieke Boon, Carmen Casaulta, Annick Clement, Suzanne Crowley, Eric Haarman, Claire Hogg, Bulent Karadag, Cordula Koerner-Rettberg, Margaret W. Leigh, Michael R. Loebinger, Henryk Mazurek, Lucy Morgan, Kim G. Nielsen, Heymut Omran, Nicolaus Schwerk, Sergio Scigliano, Claudius Werner, Panayiotis Yiallouros, Zorica Zivkovic, Jane S. Lucas, Claudia E.Kuehni, on behalf of the PCD Italian Consortium, on behalf of the Swiss PCD Group, on behalf of the French Reference Centre for Rare Lung Diseases, on behalf of the Genetic Disorders of Mucociliary Clearance Consortium Eur Respir J 2017; 49(1): 1601181; DOI: 10.1183/13993003.01181-2016 | |
Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study Carme Font, Alberto Carmona-Bayonas, Carmen Beato, Òscar Reig, Antonia Sáez, Paula Jiménez-Fonseca, Juana M.Plasencia, David Calvo-Temprano, Marcelo Sanchez, Mariana Benegas, Mercedes Biosca, Diego Varona, Maria AngelesVicente, Laura Faez, Maria del Pilar Solís, Irma de la Haba, Maite Antonio, Olga Madridano, Eduardo Castañon, María JoseMartinez, Pablo Marchena, Avinash Ramchandani, Angel Dominguez, Alejandro Puerta, David Martinez de la Haza, JesusPueyo, Susana Hernandez, Angela Fernandez-Plaza, Lourdes Martinez-Encarnacion, Mar Martin, Gema Marin, FranciscoAyala, Vicente Vicente, Remedios Otero, on behalf of the Asociación para la Investigación de la Enfermedad Tromboembólica de la región de Murcia Eur Respir J 2017; 49(1): 1600282; DOI: 10.1183/13993003.00282-2016 | |
Management of stage I and II nonsmall cell lung cancer Fiona McDonald, Michèle De Waele, Lizza E. L. Hendriks, Corinne Faivre-Finn, Anne-Marie C. Dingemans, Paul E. Van Schil Eur Respir J 2017; 49(1): 1600764; DOI: 10.1183/13993003.00764-2016 | |
Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies Samuel T. Montgomery, Marcus A. Mall, Anthony Kicic, Stephen M. Stick, on behalf of AREST CF Eur Respir J 2017; 49(1): 1600903; DOI: 10.1183/13993003.00903-2016 | |
Applicability of the World Health Organization recommended new shorter regimen in a multidrug-resistant tuberculosis high burden country Arshad Javaid, Nafees Ahmad, Amer Hayat Khan, Zubair Shaheen Eur Respir J 2017; 49(1): 1601967; DOI: 10.1183/13993003.01967-2016 | |
Telomere length, COPD and emphysema as risk factors for lung cancer Juan P. de-Torres, Pablo Sanchez-Salcedo, Gorka Bastarrika, Ana B. Alcaide, Rubén Pío, María Jose Pajares, ArantzaCampo, Juan Berto, Luis Montuenga, Maria del Mar Ocon, Carmen Monente, Bartolome R. Celli, Javier J. Zulueta Eur Respir J 2017; 49(1): 1601521; DOI: 10.1183/13993003.01521-2016 | |
Statins reduce the burden of ambient particulate matter and inflammatory cells within the lung tissues of smokers with and without COPD Kunihiko Hiraiwa, Sally Miller, David A. Ngan, Drago? M. Vasilescu, Tillie-Louise Hackett, Daisuke Kinose, Jui ChihCheng, Stephan F. van Eeden Eur Respir J 2017; 49(1): 1601689; DOI: 10.1183/13993003.01689-2016 | |
Physical activity, airway resistance and small airway dysfunction in severe asthma Thomas Bahmer, Benjamin Waschki, Fee Schatz, Christian Herzmann, Peter Zabel, Anne-Marie Kirsten, Klaus F. Rabe, Henrik Watz, the ERA-Study Group Eur Respir J 2017; 49(1): 1601827; DOI: 10.1183/13993003.01827-2016 | |
Efficacy and safety of extended antithrombotic prophylaxis in elderly medically ill patients Francesco Dentali, Nicola Mumoli, Andrea Fontanella, Matteo Nicola Dario Di Minno Eur Respir J 2017; 49(1): 1601887; DOI: 10.1183/13993003.01887-2016 | |
A new alphabet for COPD care: where “E” stands for España Robert P. Young, Raewyn J. Hopkins Eur Respir J 2017; 49(1): 1601970; DOI: 10.1183/13993003.01970-2016 | |
A new alphabet for COPD care: where “E” stands for España Edward Kerwin Eur Respir J 2017; 49(1): 1602067; DOI: 10.1183/13993003.02067-2016 | |
Dynamic near-infrared spectroscopy assessment as an important tool to explore pulmonary arterial hypertension pathophysiology Stavros Dimopoulos, Giorgos Tzanis, Andreas Karabinis, Serafim Nanas Eur Respir J 2017; 49(1): 1601932; DOI: 10.1183/13993003.01932-2016 | |
Dynamic near-infrared spectroscopy assessment as an important tool to explore pulmonary arterial hypertension pathophysiology Marios Panagiotou, Ioannis Vogiatzis, Zafeiris Louvaris, Geeshath Jayasekera, Alison McKenzie, Neil Mcglinchey, Julien S. Baker, Alistair C. Church, Andrew J. Peacock, Martin K. Johnson Eur Respir J 2017; 49(1): 1602161; DOI: 10.1183/13993003.02161-2016 | |